Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AI Proteins
AI Proteins

AI Proteins

Series B

AI Proteins: A biotech firm specializing in the design and engineering of synthetic mini protein therapeutics.

HQ
Boston, MA, US
Founded
2021
Overview
Compare
Fundraising
Employees

AI Proteins is a biotechnology firm dedicated to re-imagining protein-based medicines by designing and engineering synthetic mini protein therapeutics. The company leverages a proprietary platform that integrates synthetic biology, robotics, automation, and artificial intelligence to rapidly develop high-potential therapeutic proteins. AI Proteins aims to create medicines with ideal therapeutic characteristics, focusing on innovative solutions in the biotech sector.

Since its founding, AI Proteins has assembled a team of experienced protein engineers and drug developers who have significantly advanced the company's technological capabilities. Their platform's ability to swiftly design and build therapeutic proteins positions AI Proteins as a leader in the synthetic biology space. The company's impact is underscored by its commitment to pioneering new approaches in protein therapeutics, contributing to the broader field of biotechnology.

AI Proteins - Similar Companies

Amide Technologies logo

Amide Technologies

amidetech.com

Aikium logo

Aikium

aikium.com

Diffuse Bio logo

Diffuse Bio

diffuse.bio

Asimov logo

Asimov

asimov.com

Ordaos logo

Ordaos

ordaos.bio

Generate Biomedicines logo

Generate Biomedicines

Tierra Biosciences logo

Tierra Biosciences

Think Bioscience logo

Think Bioscience

BioMap logo

BioMap

biomap.com

Peptilogics logo

Peptilogics

peptilogics.com

20n Bio logo

20n Bio

20n.bio

Juvena Therapeutics logo

Juvena Therapeutics

BioAI Health logo

BioAI Health

bioaihealth.com

Aperiam Bio logo

Aperiam Bio

aperiambio.com

TenSixty Biosciences logo

TenSixty Biosciences

tensixty.bio

AI Proteins - Quick Facts

Who are AI Proteins' competitors?

Companies similar to AI Proteins include Amide Technologies, Aikium, Diffuse Bio and Asimov.

When was AI Proteins founded?

AI Proteins was founded in 2021.

Where is AI Proteins' headquarters located?

AI Proteins' headquarters is located in Boston, MA, US.

How much has AI Proteins raised to-date?

As of May 9, 2023, AI Proteins has raised a total of $18.2M (USD).

How many employees does AI Proteins have?

AI Proteins has 44 employees as of Feb 5, 2024.

AI Proteins - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Protein Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified